Current Activities of the Coalition of Cancer Cooperative Groups

Coalition of Cancer Cooperative Groups

Research output: Contribution to journalArticle

Abstract

The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalJournal of the National Cancer Institute
Volume111
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Clinical Trials
Research
National Cancer Institute (U.S.)
Neoplasms
Private Sector
Research Personnel
Organizations
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Current Activities of the Coalition of Cancer Cooperative Groups. / Coalition of Cancer Cooperative Groups.

In: Journal of the National Cancer Institute, Vol. 111, No. 1, 01.01.2019, p. 11-18.

Research output: Contribution to journalArticle

Coalition of Cancer Cooperative Groups. / Current Activities of the Coalition of Cancer Cooperative Groups. In: Journal of the National Cancer Institute. 2019 ; Vol. 111, No. 1. pp. 11-18.
@article{c5e8e31b6fc04473a91c6ea4c5c01b55,
title = "Current Activities of the Coalition of Cancer Cooperative Groups",
abstract = "The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.",
author = "{Coalition of Cancer Cooperative Groups} and Bertagnolli, {Monica M.} and Blaney, {Susan M.} and Charles Blanke and Curran, {Walter J.} and Janet Dancey and Mannel, {Robert S.} and O'Dwyer, {Peter J.} and Schnall, {Mitchell D.} and Norman Wolmark",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/jnci/djy190",
language = "English (US)",
volume = "111",
pages = "11--18",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Current Activities of the Coalition of Cancer Cooperative Groups

AU - Coalition of Cancer Cooperative Groups

AU - Bertagnolli, Monica M.

AU - Blaney, Susan M.

AU - Blanke, Charles

AU - Curran, Walter J.

AU - Dancey, Janet

AU - Mannel, Robert S.

AU - O'Dwyer, Peter J.

AU - Schnall, Mitchell D.

AU - Wolmark, Norman

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.

AB - The Coalition of Cancer Cooperative Groups is an organization representing the interests of patients and researchers who conduct research through the National Cancer Institute-supported National Clinical Trials Network (NCTN). The NCTN provides a crucial mechanism for executing practice-changing cancer clinical research to achieve both cancer control and development of new therapeutic agents or modality approaches. Public funding, largely through the National Cancer Institute, ensures that the work of the NCTN achieves important research that would not otherwise be accomplished in the private sector. In fall 2017, the Coalition of Cancer Cooperative Groups convened a Scientific Leadership Council to review the current state of the network with regard to research capabilities and to develop a list of research questions to be prioritized by the network. This report presents the results of this meeting, detailing a roadmap for future work by the NCTN.

UR - http://www.scopus.com/inward/record.url?scp=85060171036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060171036&partnerID=8YFLogxK

U2 - 10.1093/jnci/djy190

DO - 10.1093/jnci/djy190

M3 - Article

C2 - 30544145

AN - SCOPUS:85060171036

VL - 111

SP - 11

EP - 18

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 1

ER -